Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 12 | 2022 | 107 | 4.890 |
Why?
|
| Spinal Cord Injuries | 8 | 2020 | 309 | 2.270 |
Why?
|
| Atlanto-Axial Joint | 3 | 2021 | 21 | 1.540 |
Why?
|
| Pedicle Screws | 2 | 2022 | 3 | 1.470 |
Why?
|
| Spinal Diseases | 2 | 2021 | 46 | 1.470 |
Why?
|
| Bone Transplantation | 5 | 2021 | 49 | 1.370 |
Why?
|
| Spinal Cord Compression | 3 | 2017 | 30 | 1.150 |
Why?
|
| Intervertebral Disc Degeneration | 5 | 2018 | 13 | 1.130 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2021 | 18 | 1.120 |
Why?
|
| Spinal Cord Diseases | 2 | 2021 | 40 | 1.110 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 109 | 1.040 |
Why?
|
| Surgical Wound Infection | 2 | 2022 | 264 | 1.000 |
Why?
|
| Cervical Vertebrae | 7 | 2021 | 107 | 0.980 |
Why?
|
| Laminectomy | 4 | 2020 | 26 | 0.980 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2022 | 61 | 0.950 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 226 | 0.950 |
Why?
|
| Occipital Bone | 3 | 2021 | 21 | 0.880 |
Why?
|
| Neck Pain | 1 | 2022 | 19 | 0.820 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2019 | 80 | 0.810 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2019 | 71 | 0.790 |
Why?
|
| Physical Examination | 1 | 2022 | 165 | 0.760 |
Why?
|
| Kyphosis | 1 | 2021 | 21 | 0.740 |
Why?
|
| Surgical Flaps | 2 | 2022 | 206 | 0.730 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 2058 | 0.680 |
Why?
|
| Radiation Injuries | 1 | 2021 | 141 | 0.680 |
Why?
|
| Spinal Neoplasms | 2 | 2017 | 59 | 0.670 |
Why?
|
| Meningocele | 1 | 2019 | 19 | 0.670 |
Why?
|
| Pseudarthrosis | 1 | 2019 | 6 | 0.650 |
Why?
|
| Neuronavigation | 1 | 2018 | 7 | 0.630 |
Why?
|
| Spondylolisthesis | 1 | 2018 | 6 | 0.630 |
Why?
|
| Postoperative Complications | 7 | 2019 | 3018 | 0.620 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 126 | 0.600 |
Why?
|
| Thoracic Vertebrae | 5 | 2022 | 66 | 0.590 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 238 | 0.580 |
Why?
|
| Epidural Abscess | 1 | 2017 | 9 | 0.560 |
Why?
|
| Tissue Scaffolds | 4 | 2019 | 74 | 0.560 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 481 | 0.540 |
Why?
|
| Meningomyelocele | 1 | 2019 | 235 | 0.530 |
Why?
|
| Disease Management | 2 | 2021 | 515 | 0.510 |
Why?
|
| Spinal Cord | 3 | 2018 | 304 | 0.490 |
Why?
|
| Humans | 46 | 2022 | 123254 | 0.470 |
Why?
|
| Genetic Therapy | 2 | 2016 | 679 | 0.410 |
Why?
|
| Angiography | 1 | 2012 | 215 | 0.390 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 125 | 0.390 |
Why?
|
| Decompressive Craniectomy | 1 | 2011 | 13 | 0.390 |
Why?
|
| Glioma | 1 | 2016 | 496 | 0.380 |
Why?
|
| Corynebacterium Infections | 1 | 2011 | 4 | 0.380 |
Why?
|
| Neurosurgical Procedures | 4 | 2022 | 299 | 0.380 |
Why?
|
| Body Fluids | 1 | 2011 | 47 | 0.380 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 220 | 0.370 |
Why?
|
| Drainage | 1 | 2012 | 257 | 0.360 |
Why?
|
| Klippel-Feil Syndrome | 2 | 2020 | 8 | 0.360 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2018 | 2586 | 0.360 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 3 | 2016 | 3 | 0.350 |
Why?
|
| Low Back Pain | 2 | 2022 | 34 | 0.350 |
Why?
|
| Brain Ischemia | 2 | 2012 | 258 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 361 | 0.340 |
Why?
|
| Abscess | 1 | 2011 | 138 | 0.340 |
Why?
|
| Spine | 2 | 2021 | 143 | 0.310 |
Why?
|
| Female | 27 | 2021 | 65598 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 1218 | 0.290 |
Why?
|
| Osteoporotic Fractures | 2 | 2018 | 24 | 0.290 |
Why?
|
| Absorbable Implants | 2 | 2018 | 23 | 0.290 |
Why?
|
| Spinal Fractures | 2 | 2018 | 39 | 0.280 |
Why?
|
| Middle Aged | 18 | 2021 | 26073 | 0.270 |
Why?
|
| Male | 23 | 2021 | 60310 | 0.270 |
Why?
|
| Aged | 12 | 2021 | 19173 | 0.270 |
Why?
|
| Hindlimb | 2 | 2017 | 75 | 0.260 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4297 | 0.240 |
Why?
|
| Stroke | 2 | 2012 | 957 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 3079 | 0.230 |
Why?
|
| Retrospective Studies | 7 | 2022 | 16056 | 0.230 |
Why?
|
| Transplantation, Autologous | 2 | 2021 | 297 | 0.210 |
Why?
|
| Acute Disease | 2 | 2017 | 1093 | 0.210 |
Why?
|
| Adult | 15 | 2022 | 29079 | 0.210 |
Why?
|
| Rats | 4 | 2019 | 3664 | 0.200 |
Why?
|
| Joint Instability | 2 | 2020 | 42 | 0.200 |
Why?
|
| Diagnosis, Differential | 3 | 2022 | 1876 | 0.200 |
Why?
|
| Hydrocephalus | 2 | 2017 | 242 | 0.200 |
Why?
|
| Lordosis | 1 | 2021 | 6 | 0.190 |
Why?
|
| Neurosurgery | 1 | 2022 | 76 | 0.190 |
Why?
|
| Foramen Magnum | 1 | 2021 | 5 | 0.190 |
Why?
|
| Scapula | 1 | 2021 | 12 | 0.190 |
Why?
|
| Ilium | 1 | 2021 | 20 | 0.190 |
Why?
|
| Fractures, Compression | 2 | 2018 | 7 | 0.180 |
Why?
|
| Cadaver | 1 | 2021 | 129 | 0.180 |
Why?
|
| Ribs | 1 | 2021 | 45 | 0.180 |
Why?
|
| Spinal Stenosis | 1 | 2020 | 9 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2017 | 829 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2022 | 6030 | 0.170 |
Why?
|
| Decompression, Surgical | 3 | 2020 | 92 | 0.170 |
Why?
|
| Subdural Effusion | 1 | 2019 | 8 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2013 | 807 | 0.160 |
Why?
|
| Coculture Techniques | 2 | 2017 | 233 | 0.160 |
Why?
|
| Contusions | 1 | 2018 | 17 | 0.160 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 15 | 0.160 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 43 | 0.150 |
Why?
|
| Thymidylate Synthase | 1 | 2018 | 22 | 0.150 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2018 | 24 | 0.150 |
Why?
|
| Arachnoid Cysts | 1 | 2017 | 8 | 0.150 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 70 | 0.150 |
Why?
|
| Dura Mater | 1 | 2017 | 26 | 0.150 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2017 | 16 | 0.140 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2017 | 17 | 0.140 |
Why?
|
| Third Ventricle | 1 | 2017 | 29 | 0.140 |
Why?
|
| Hemangioma, Cavernous | 1 | 2017 | 19 | 0.140 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 27 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 87 | 0.140 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 95 | 0.140 |
Why?
|
| Craniotomy | 2 | 2020 | 108 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2020 | 332 | 0.140 |
Why?
|
| Chondrosarcoma | 1 | 2016 | 10 | 0.140 |
Why?
|
| Flucytosine | 1 | 2016 | 17 | 0.140 |
Why?
|
| Cytosine Deaminase | 1 | 2016 | 20 | 0.140 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 73 | 0.140 |
Why?
|
| Locomotion | 1 | 2017 | 69 | 0.130 |
Why?
|
| Thymidine Kinase | 1 | 2016 | 95 | 0.130 |
Why?
|
| Osteotomy | 1 | 2016 | 39 | 0.130 |
Why?
|
| Ganciclovir | 1 | 2016 | 102 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 147 | 0.130 |
Why?
|
| Fluorouracil | 1 | 2016 | 128 | 0.130 |
Why?
|
| Scoliosis | 1 | 2017 | 134 | 0.130 |
Why?
|
| Spinal Dysraphism | 1 | 2019 | 265 | 0.130 |
Why?
|
| Reoperation | 1 | 2019 | 819 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2016 | 161 | 0.130 |
Why?
|
| Reflex | 1 | 2015 | 52 | 0.120 |
Why?
|
| Total Disc Replacement | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cervical Cord | 1 | 2015 | 9 | 0.120 |
Why?
|
| Animals | 7 | 2019 | 33837 | 0.120 |
Why?
|
| Joint Prosthesis | 1 | 2015 | 15 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 293 | 0.120 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 54 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 437 | 0.120 |
Why?
|
| Myelin Sheath | 1 | 2015 | 132 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 433 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 182 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2018 | 3239 | 0.110 |
Why?
|
| Republic of Korea | 4 | 2016 | 37 | 0.110 |
Why?
|
| Population | 1 | 2013 | 21 | 0.110 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2013 | 5 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2013 | 14 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 883 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 259 | 0.110 |
Why?
|
| Radiography | 2 | 2015 | 822 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2015 | 1013 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 3549 | 0.110 |
Why?
|
| Blood Patch, Epidural | 1 | 2012 | 6 | 0.110 |
Why?
|
| Intracranial Hypotension | 1 | 2012 | 10 | 0.110 |
Why?
|
| Sesquiterpenes | 1 | 2013 | 22 | 0.110 |
Why?
|
| Alkaloids | 1 | 2013 | 33 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.100 |
Why?
|
| Urinary Incontinence | 1 | 2012 | 69 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 220 | 0.100 |
Why?
|
| Fecal Incontinence | 1 | 2012 | 69 | 0.100 |
Why?
|
| Melanoma | 1 | 2019 | 824 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2022 | 1159 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Brain Infarction | 1 | 2012 | 30 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 413 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4515 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6385 | 0.090 |
Why?
|
| Pain | 1 | 2013 | 470 | 0.080 |
Why?
|
| Genotype | 4 | 2017 | 2537 | 0.080 |
Why?
|
| Back Pain | 2 | 2022 | 27 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 1405 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2017 | 12165 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 6222 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2017 | 358 | 0.060 |
Why?
|
| Haplotypes | 2 | 2016 | 517 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2016 | 715 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 79 | 0.050 |
Why?
|
| Workload | 1 | 2022 | 147 | 0.050 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2020 | 6 | 0.040 |
Why?
|
| Odontoid Process | 1 | 2020 | 7 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 303 | 0.040 |
Why?
|
| Alleles | 2 | 2016 | 1603 | 0.040 |
Why?
|
| Bone Wires | 1 | 2019 | 6 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 392 | 0.040 |
Why?
|
| Bone Screws | 1 | 2019 | 51 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1911 | 0.040 |
Why?
|
| Polyesters | 1 | 2018 | 40 | 0.040 |
Why?
|
| Polyradiculopathy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2017 | 47 | 0.040 |
Why?
|
| Intervertebral Disc | 1 | 2017 | 12 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 198 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 507 | 0.040 |
Why?
|
| Young Adult | 3 | 2017 | 8867 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 152 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 165 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5049 | 0.030 |
Why?
|
| Postmenopause | 1 | 2017 | 125 | 0.030 |
Why?
|
| Water | 1 | 2017 | 182 | 0.030 |
Why?
|
| Headache | 1 | 2017 | 108 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2016 | 195 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 106 | 0.030 |
Why?
|
| Cell Engineering | 1 | 2015 | 21 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 2015 | 11 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2015 | 29 | 0.030 |
Why?
|
| Dipeptides | 1 | 2015 | 59 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 65 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 464 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 191 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 348 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 756 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2013 | 143 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 1167 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 395 | 0.030 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 35 | 0.030 |
Why?
|
| Survival | 1 | 2012 | 19 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 381 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 1390 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 798 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 204 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 543 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 105 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 73 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1449 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 1040 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 476 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 760 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3045 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2012 | 762 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 19131 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1236 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 4499 | 0.010 |
Why?
|